BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 16828977)

  • 1. Do individuals with a severe mental illness experience greater alcohol and drug-related problems? A test of the supersensitivity hypothesis.
    Gonzalez VM; Bradizza CM; Vincent PC; Stasiewicz PR; Paas ND
    Addict Behav; 2007 Mar; 32(3):477-90. PubMed ID: 16828977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Personality in male patients with substance use disorder and/or severe mental illness.
    Fernández-Mondragón S; Adan A
    Psychiatry Res; 2015 Aug; 228(3):488-94. PubMed ID: 26144586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gender differences in substance use, consequences, motivation to change, and treatment seeking in people with serious mental illness.
    Drapalski A; Bennett M; Bellack A
    Subst Use Misuse; 2011; 46(6):808-18. PubMed ID: 21174496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Qualitative analysis of high-risk drug and alcohol use situations among severely mentally ill substance abusers.
    Bradizza CM; Stasiewicz PR
    Addict Behav; 2003; 28(1):157-69. PubMed ID: 12507534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The associations between substance use disorders, schizophrenia-spectrum disorders, and Axis IV psychosocial problems.
    Compton MT; Weiss PS; West JC; Kaslow NJ
    Soc Psychiatry Psychiatr Epidemiol; 2005 Dec; 40(12):939-46. PubMed ID: 16247563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensation-seeking, social anhedonia, and impulsivity in substance use disorder patients with and without schizophrenia and in non-abusing schizophrenia patients.
    Zhornitsky S; Rizkallah E; Pampoulova T; Chiasson JP; Lipp O; Stip E; Potvin S
    Psychiatry Res; 2012 Dec; 200(2-3):237-41. PubMed ID: 22980481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of substance use disorder on the clinical presentation of anxiety and depression in an outpatient psychiatric clinic.
    Tsuang D; Cowley D; Ries R; Dunner DL; Roy-Byrne PP
    J Clin Psychiatry; 1995 Dec; 56(12):549-55. PubMed ID: 8530330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temperament and character dimensions in male patients with substance use disorders: Differences relating to psychiatric comorbidity.
    Marquez-Arrico JE; López-Vera S; Prat G; Adan A
    Psychiatry Res; 2016 Mar; 237():1-8. PubMed ID: 26921044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlates of dependence and treatment for substance use among people with comorbid severe mental and substance use disorders: findings from the "Psychiatric and Addictive Dual Disorder in Italy (PADDI)" Study.
    Carrà G; Crocamo C; Borrelli P; Popa I; Ornaghi A; Montomoli C; Clerici M
    Compr Psychiatry; 2015 Apr; 58():152-9. PubMed ID: 25591906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Dual diagnosis psychosis and substance use disorders in adolescents--part 1].
    Meister K; Burlon M; Rietschel L; Gouzoulis-Mayfrank E; Bock T; Lambert M
    Fortschr Neurol Psychiatr; 2010 Feb; 78(2):81-9. PubMed ID: 20146152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychiatric comorbidity and severity of dependence on substance users: how it impacts on their health-related quality of life?
    Lozano ÓM; Rojas AJ; Fernández Calderón F
    J Ment Health; 2017 Apr; 26(2):119-126. PubMed ID: 27128492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The vulnerability to alcohol and substance abuse in individuals diagnosed with schizophrenia.
    Krystal JH; D'Souza DC; Gallinat J; Driesen N; Abi-Dargham A; Petrakis I; Heinz A; Pearlson G
    Neurotox Res; 2006 Dec; 10(3-4):235-52. PubMed ID: 17197373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expectations and motives for substance use in schizophrenia.
    Mueser KT; Nishith P; Tracy JI; DeGirolamo J; Molinaro M
    Schizophr Bull; 1995; 21(3):367-78. PubMed ID: 7481568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extrapyramidal symptoms in substance abusers with and without schizophrenia and in nonabusing patients with schizophrenia.
    Zhornitsky S; Stip E; Pampoulova T; Rizkallah E; Lipp O; Bentaleb LA; Chiasson JP; Potvin S
    Mov Disord; 2010 Oct; 25(13):2188-94. PubMed ID: 20669315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comorbid substance abuse and neurocognitive function in recent-onset schizophrenia.
    Wobrock T; Sittinger H; Behrendt B; D'Amelio R; Falkai P; Caspari D
    Eur Arch Psychiatry Clin Neurosci; 2007 Jun; 257(4):203-10. PubMed ID: 17131214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of improvement in quality of life of severely mentally ill substance abusers during 18 months of co-operation between psychiatric and social services.
    Schaar I; Ojehagen A
    Soc Psychiatry Psychiatr Epidemiol; 2003 Feb; 38(2):83-7. PubMed ID: 12563550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dually diagnosed patients' responses to substance use disorder treatment.
    Boden MT; Moos R
    J Subst Abuse Treat; 2009 Dec; 37(4):335-45. PubMed ID: 19540699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sexual risk behavior among persons dually diagnosed with severe mental illness and substance use disorder.
    Meade CS
    J Subst Abuse Treat; 2006 Mar; 30(2):147-57. PubMed ID: 16490678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of severe mental illness and substance misuse.
    Watts M
    Nurs Times; 2007 Apr 3-9; 103(14):28-9. PubMed ID: 17455515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High inpatient utilization among Veterans Health Administration patients with substance-use disorders and co-occurring mental health conditions.
    Painter JM; Malte CA; Rubinsky AD; Campellone TR; Gilmore AK; Baer JS; Hawkins EJ
    Am J Drug Alcohol Abuse; 2018; 44(3):386-394. PubMed ID: 29095057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.